Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$309,285
-$250,557 QoQ
Shares Held
4,304
-9.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Graham Capital Management, L.P. holds $4,664,055 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #7 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
75,653 | $1,212,717 | |
| 2 | HLN |
Haleon plc
|
55,057 | $513,681 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
101,971 | $502,717 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
24,035 | $416,045 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
7,136 | $337,318 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
8,555 | $309,691 | |
| 7 | ZTS |
Zoetis Inc.
This page
|
4,304 | $309,285 | |
| 8 | PRGO |
PERRIGO Co plc
|
28,290 | $293,933 |
All Filings in ZTS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $309,285 | 4,304 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $559,842 | 4,736 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $2,779,496 | 17,823 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $332,836 | 1,967 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $2,304,028 | 13,843 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||